Financial Performance - For the first quarter of 2025, the company's unaudited consolidated revenue was HKD 2.879 billion, representing a 20% increase compared to HKD 2.399 billion in the same period last year[4]. - The profit attributable to equity holders of the company for the first quarter of 2025 was HKD 34.77 million, a significant increase of 260% from HKD 9.65 million in the previous year[4]. - The total assets as of March 31, 2025, were HKD 5.035 billion, reflecting a 2% increase from HKD 4.938 billion as of December 31, 2024[4]. Segment Performance - The food biotechnology segment generated revenue of HKD 2.355 billion, a 21% increase year-on-year, despite a 7% decline in segment profit to HKD 44.59 million[7]. - The tinplate business produced 76,000 tons of products, a 10% increase year-on-year, with sales of 75,000 tons, representing a 19% increase[8]. - The revenue from the tinplate business was HKD 520 million, a 15% increase compared to the previous year, with segment profit rising 314% to HKD 19.76 million[8]. Challenges and Considerations - The company expects to continue facing challenges due to price fluctuations in pork and demand variability in the tinplate business[12]. - The company emphasizes that quarterly performance may not be indicative of annual results due to market conditions and seasonal factors[12]. Asset Valuation - The company has not recorded any valuation gains or losses on investment properties, maintaining stable property values[10]. - The unaudited financial data for the first quarter of 2025 has been reviewed by the company's audit committee[11].
广南(集团)(01203) - 2025 Q1 - 季度业绩